BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25477375)

  • 1. Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice.
    Woods SE; Leonard MR; Hayden JA; Brophy MB; Bernert KR; Lavoie B; Muthupalani S; Whary MT; Mawe GM; Nolan EM; Carey MC; Fox JG
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G335-49. PubMed ID: 25477375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.
    Freudenberg F; Leonard MR; Liu SA; Glickman JN; Carey MC
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G205-14. PubMed ID: 20430874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.
    Wang HH; Liu M; Portincasa P; Tso P; Wang DQ
    Neurogastroenterol Motil; 2016 Mar; 28(3):364-75. PubMed ID: 26604077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct contractile response of isolated gallbladder smooth muscle cells to cholecystokinin in patients with gallstones.
    Chijiiwa K; Yamasaki T; Chijiiwa Y
    J Surg Res; 1994 May; 56(5):434-8. PubMed ID: 8170143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
    Wang HH; Portincasa P; Wang DQ
    Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility.
    Xiao Z; Schmitz F; Pricolo VE; Biancani P; Behar J
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1641-9. PubMed ID: 17307729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pathophysiological concepts underlying pathogenesis of pigment gallstones.
    VĂ­tek L; Carey MC
    Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):122-9. PubMed ID: 21978438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for
    Wang HH; Portincasa P; Liu M; Tso P; Wang DQ
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus.
    Ding X; Lu CY; Mei Y; Liu CA; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):295-8. PubMed ID: 15908333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.
    Portincasa P; Di Ciaula A; Vendemiale G; Palmieri V; Moschetta A; Vanberge-Henegouwen GP; Palasciano G
    Eur J Clin Invest; 2000 Apr; 30(4):317-24. PubMed ID: 10759880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.
    Wang HH; Liu M; Li X; Portincasa P; Wang DQ
    Eur J Clin Invest; 2017 Apr; 47(4):328-333. PubMed ID: 28186337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of gallstones.
    Carey MC
    Recenti Prog Med; 1992; 83(7-8):379-91. PubMed ID: 1529152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous elevation of plasma cholecystokinin does not prevent gallstones.
    Shahid RA; Wang DQ; Fee BE; McCall SJ; Romac JM; Vigna SR; Liddle RA
    Eur J Clin Invest; 2015 Mar; 45(3):237-46. PubMed ID: 25641074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.
    Tharp KM; Khalifeh-Soltani A; Park HM; Yurek DA; Falcon A; Wong L; Feng R; Atabai K; Stahl A
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G855-64. PubMed ID: 27033116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease.
    Brink MA; Slors JF; Keulemans YC; Mok KS; De Waart DR; Carey MC; Groen AK; Tytgat GN
    Gastroenterology; 1999 Jun; 116(6):1420-7. PubMed ID: 10348826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones.
    Upp JR; Nealon WH; Singh P; Fagan CJ; Jonas AS; Greeley GH; Thompson JC
    Ann Surg; 1987 Jun; 205(6):641-8. PubMed ID: 3592806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of gallstones.
    Carey MC
    Am J Surg; 1993 Apr; 165(4):410-9. PubMed ID: 8480873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interstitial Cajal-like cells in the formation of cholesterol stones in guinea pig gallbladder.
    Fan Y; Wu S; Fu B; Weng C; Wang X
    Hepatol Int; 2015 Oct; 9(4):612-20. PubMed ID: 25788205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function.
    van Erpecum KJ; Wang DQ; Moschetta A; Ferri D; Svelto M; Portincasa P; Hendrickx JJ; Schipper M; Calamita G
    J Lipid Res; 2006 Jan; 47(1):32-41. PubMed ID: 16224116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.